TY - JOUR
T1 - Clinical guidelines for primary sclerosing cholangitis 2017
AU - PSC guideline committee Members: Ministry of Health, Labour and Welfare (Japan) Research Project, The Intractable Hepatobiliary Disease Study Group
AU - Isayama, Hiroyuki
AU - Tazuma, Susumu
AU - Kokudo, Norihiro
AU - Tanaka, Atsushi
AU - Tsuyuguchi, Toshio
AU - Nakazawa, Takahiro
AU - Notohara, Kenji
AU - Mizuno, Suguru
AU - Akamatsu, Nobuhisa
AU - Serikawa, Masahiro
AU - Naitoh, Itaru
AU - Hirooka, Yoshiki
AU - Wakai, Toshifumi
AU - Itoi, Takao
AU - Ebata, Tomoki
AU - Okaniwa, Shinji
AU - Kamisawa, Terumi
AU - Kawashima, Hiroki
AU - Kanno, Atsushi
AU - Kubota, Keiichi
AU - Tabata, Masami
AU - Unno, Michiaki
AU - Takikawa, Hajime
N1 - Publisher Copyright:
© 2018, Japanese Society of Gastroenterology.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Background: Primary sclerosing cholangitis (PSC) is relatively rare disease and pathogenesis and methods of treatments were still not established. Then, we had conducted the making clinical guidelines to manage patients with PSC based on the literature review and expert opinions. These clinical guidelines were made for the medical doctors on the management of PSC, except child case of PSC. Methods: We had employed modified Delphi method. The production committee decided guidelines, strength of recommendations and evidence level after reviewed literatures systematically, and The Expert panel evaluated those. The Scientific Committee of the Japan Biliary Association (JBA) evaluated revised guidelines, and the Public comments were collected on web site of JBA. Results: We had made 16 guidelines about epidemiology/pathophysiology, diagnostics, therapy and prognosis. Also, we had made both diagnostic and therapeutic flow chart. Conclusions: We hope that these guidelines will contribute to the improvement and development of the medical care of PSC.
AB - Background: Primary sclerosing cholangitis (PSC) is relatively rare disease and pathogenesis and methods of treatments were still not established. Then, we had conducted the making clinical guidelines to manage patients with PSC based on the literature review and expert opinions. These clinical guidelines were made for the medical doctors on the management of PSC, except child case of PSC. Methods: We had employed modified Delphi method. The production committee decided guidelines, strength of recommendations and evidence level after reviewed literatures systematically, and The Expert panel evaluated those. The Scientific Committee of the Japan Biliary Association (JBA) evaluated revised guidelines, and the Public comments were collected on web site of JBA. Results: We had made 16 guidelines about epidemiology/pathophysiology, diagnostics, therapy and prognosis. Also, we had made both diagnostic and therapeutic flow chart. Conclusions: We hope that these guidelines will contribute to the improvement and development of the medical care of PSC.
UR - http://www.scopus.com/inward/record.url?scp=85049117726&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049117726&partnerID=8YFLogxK
U2 - 10.1007/s00535-018-1484-9
DO - 10.1007/s00535-018-1484-9
M3 - Review article
C2 - 29951926
AN - SCOPUS:85049117726
SN - 0944-1174
VL - 53
SP - 1006
EP - 1034
JO - Journal of Gastroenterology
JF - Journal of Gastroenterology
IS - 9
ER -